BCRX

Neutral

Biocryst (BCRX) grants Theresa Heggie RSUs and stock options as board pay

BioCryst Pharmaceuticals director Theresa Heggie received equity awards, including 15,294 Restricted Stock Units and an automatic stock option grant f...

Stock Titan 6 days ago 0

Bullish

BioCryst highlights efficacy gains across hereditary angioedema portfolio

BioCryst Pharmaceuticals presented new clinical trial data and real-world evidence for its hereditary angioedema (HAE) portfolio at the EAACI 2026 Ann...

grafa.com 1 week ago 0